Avidicure B.V.
Monday, June 03, 2024
Company Presentation
![Oncology](https://cdn.asp.events/CLIENT_BIO_7BB99CBA_BAD1_B8C8_CF9F25DA29A80CC6/sites/BIOIC-2024/media/icons/seminars/BIO-track-icon_Oncology_MTC.png)
Company Presentation Theater 4
Avidicure develops AVC-Boosters for cancer immunotherapy. AVC-Boosters are supercharged antibodies that boost the number and function of NK cells at the tumor, cause activation of the full immune system and provide broad TME-resistant anti-tumor responses.
![Avidicure B.V.](https://www.abstractscorecard.com/uploads/Tasks/upload/21754/XDQDGWMO-1801722-1-JPG.png)
Company Website:
http://www.avidicure.com
Lead Product in Development:
AVC boosters
Company HQ City
Naarden
Company HQ State
N-Holland
Company HQ Country
Netherlands
CEO/Top Company Official
Arthur Lahr CEO
Development Phase of Primary Product
Discovery
Primary Speaker